Literature DB >> 32351122

The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.

Rachit Badolia1,2, Dinesh K A Ramadurai1, E Dale Abel3, Peter Ferrin1, Iosif Taleb1,2, Thirupura S Shankar1, Aspasia Thodou Krokidi1, Sutip Navankasattusas1, Stephen H McKellar2, Michael Yin2, Abdallah G Kfoury2, Omar Wever-Pinzon2, James C Fang2, Craig H Selzman1,2, Dipayan Chaudhuri1, Jared Rutter4, Stavros G Drakos1,2.   

Abstract

BACKGROUND: Significant improvements in myocardial structure and function have been reported in some patients with advanced heart failure (termed responders [R]) following left ventricular assist device (LVAD)-induced mechanical unloading. This therapeutic strategy may alter myocardial energy metabolism in a manner that reverses the deleterious metabolic adaptations of the failing heart. Specifically, our previous work demonstrated a post-LVAD dissociation of glycolysis and oxidative-phosphorylation characterized by induction of glycolysis without subsequent increase in pyruvate oxidation through the tricarboxylic acid cycle. The underlying mechanisms responsible for this dissociation are not well understood. We hypothesized that the accumulated glycolytic intermediates are channeled into cardioprotective and repair pathways, such as the pentose-phosphate pathway and 1-carbon metabolism, which may mediate myocardial recovery in R.
METHODS: We prospectively obtained paired left ventricular apical myocardial tissue from nonfailing donor hearts as well as R and nonresponders at LVAD implantation (pre-LVAD) and transplantation (post-LVAD). We conducted protein expression and metabolite profiling and evaluated mitochondrial structure using electron microscopy.
RESULTS: Western blot analysis shows significant increase in rate-limiting enzymes of pentose-phosphate pathway and 1-carbon metabolism in post-LVAD R (post-R) as compared with post-LVAD nonresponders (post-NR). The metabolite levels of these enzyme substrates, such as sedoheptulose-6-phosphate (pentose phosphate pathway) and serine and glycine (1-carbon metabolism) were also decreased in Post-R. Furthermore, post-R had significantly higher reduced nicotinamide adenine dinucleotide phosphate levels, reduced reactive oxygen species levels, improved mitochondrial density, and enhanced glycosylation of the extracellular matrix protein, α-dystroglycan, all consistent with enhanced pentose-phosphate pathway and 1-carbon metabolism that correlated with the observed myocardial recovery.
CONCLUSIONS: The recovering heart appears to direct glycolytic metabolites into pentose-phosphate pathway and 1-carbon metabolism, which could contribute to cardioprotection by generating reduced nicotinamide adenine dinucleotide phosphate to enhance biosynthesis and by reducing oxidative stress. These findings provide further insights into mechanisms responsible for the beneficial effect of glycolysis induction during the recovery of failing human hearts after mechanical unloading.

Entities:  

Keywords:  glucose metabolism; heart failure; left ventricular assist device; myocardial recovery; one-carbon metabolism; pentose phosphate pathway; reverse remodeling

Year:  2020        PMID: 32351122      PMCID: PMC7380956          DOI: 10.1161/CIRCULATIONAHA.119.044452

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

Review 1.  Reverse remodeling during long-term mechanical unloading of the left ventricle.

Authors:  Stavros G Drakos; John V Terrovitis; Maria I Anastasiou-Nana; John N Nanas
Journal:  J Mol Cell Cardiol       Date:  2007-06-06       Impact factor: 5.000

2.  Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward.

Authors:  Stavros G Drakos; Mandeep R Mehra
Journal:  J Heart Lung Transplant       Date:  2016-01-13       Impact factor: 10.247

Review 3.  One-Carbon Metabolism in Health and Disease.

Authors:  Gregory S Ducker; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2016-09-15       Impact factor: 27.287

4.  Central role for aldose reductase pathway in myocardial ischemic injury.

Authors:  Yuying C Hwang; Michiyo Kaneko; Soliman Bakr; Hui Liao; Yan Lu; Erin R Lewis; Shidu Yan; Setsuko Ii; Mitsuo Itakura; Liu Rui; Hal Skopicki; Shunichi Homma; Ann Marie Schmidt; Peter J Oates; Matthias Szabolcs; Ravichandran Ramasamy
Journal:  FASEB J       Date:  2004-08       Impact factor: 5.191

5.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

6.  Mechanical unloading promotes myocardial energy recovery in human heart failure.

Authors:  Anisha A Gupte; Dale J Hamilton; Andrea M Cordero-Reyes; Keith A Youker; Zheng Yin; Jerry D Estep; Robert D Stevens; Brett Wenner; Olga Ilkayeva; Matthias Loebe; Leif E Peterson; Christopher J Lyon; Stephen T C Wong; Christopher B Newgard; Guillermo Torre-Amione; Heinrich Taegtmeyer; Willa A Hsueh
Journal:  Circ Cardiovasc Genet       Date:  2014-05-13

7.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts.

Authors:  M F Allard; B O Schönekess; S L Henning; D R English; G D Lopaschuk
Journal:  Am J Physiol       Date:  1994-08

8.  Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.

Authors:  Aalap Chokshi; Konstantinos Drosatos; Faisal H Cheema; Ruiping Ji; Tuba Khawaja; Shuiqing Yu; Tomoko Kato; Raffay Khan; Hiroo Takayama; Ralph Knöll; Hendrik Milting; Christine S Chung; Ulrich Jorde; Yoshifumi Naka; Donna M Mancini; Ira J Goldberg; P Christian Schulze
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

9.  Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission.

Authors:  Kensuke Tsushima; Heiko Bugger; Adam R Wende; Jamie Soto; Gregory A Jenson; Austin R Tor; Rose McGlauflin; Helena C Kenny; Yuan Zhang; Rhonda Souvenir; Xiao X Hu; Crystal L Sloan; Renata O Pereira; Vitor A Lira; Kenneth W Spitzer; Terry L Sharp; Kooresh I Shoghi; Genevieve C Sparagna; Eva A Rog-Zielinska; Peter Kohl; Oleh Khalimonchuk; Jean E Schaffer; E Dale Abel
Journal:  Circ Res       Date:  2017-11-01       Impact factor: 17.367

10.  Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.

Authors:  Marcela P Cataldi; Peijuan Lu; Anthony Blaeser; Qi Long Lu
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919

View more
  15 in total

1.  FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure.

Authors:  Salah Sommakia; Naredos H Almaw; Sandra H Lee; Dinesh K A Ramadurai; Iosif Taleb; Christos P Kyriakopoulos; Chris J Stubben; Jing Ling; Robert A Campbell; Rami A Alharethi; William T Caine; Sutip Navankasattusas; Guillaume L Hoareau; Anu E Abraham; James C Fang; Craig H Selzman; Stavros G Drakos; Dipayan Chaudhuri
Journal:  Circ Heart Fail       Date:  2021-12-06       Impact factor: 8.790

Review 2.  LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement.

Authors:  Christos P Kyriakopoulos; Chris J Kapelios; Elizabeth L Stauder; Iosif Taleb; Rana Hamouche; Konstantinos Sideris; Antigone G Koliopoulou; Michael J Bonios; Stavros G Drakos
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

Review 3.  Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology.

Authors:  Anja Karlstaedt; Matthew Barrett; Ray Hu; Seth Thomas Gammons; Bonnie Ky
Journal:  JACC Basic Transl Sci       Date:  2021-07-28

Review 4.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

5.  It takes a village: lessons from collaborative science.

Authors:  E Dale Abel
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

6.  The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure.

Authors:  Ahmad A Cluntun; Rachit Badolia; Sandra Lettlova; K Mark Parnell; Thirupura S Shankar; Nikolaos A Diakos; Kristofor A Olson; Iosif Taleb; Sean M Tatum; Jordan A Berg; Corey N Cunningham; Tyler Van Ry; Alex J Bott; Aspasia Thodou Krokidi; Sarah Fogarty; Sophia Skedros; Wojciech I Swiatek; Xuejing Yu; Bai Luo; Shannon Merx; Sutip Navankasattusas; James E Cox; Gregory S Ducker; William L Holland; Stephen H McKellar; Jared Rutter; Stavros G Drakos
Journal:  Cell Metab       Date:  2020-12-16       Impact factor: 27.287

Review 7.  Reverse Remodeling With Left Ventricular Assist Devices.

Authors:  Daniel Burkhoff; Veli K Topkara; Gabriel Sayer; Nir Uriel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 23.213

Review 8.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 9.  Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy.

Authors:  Mingyao Huang; Liang Yang; Xueqiang Peng; Shibo Wei; Qing Fan; Shuo Yang; Xinyu Li; Bowen Li; Hongyuan Jin; Bo Wu; Jingang Liu; Hangyu Li
Journal:  J Exp Clin Cancer Res       Date:  2020-09-14

10.  Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3.

Authors:  Jing Zhang; Peng Yu; Fuzhou Hua; Yanhui Hu; Fan Xiao; Qin Liu; Dan Huang; Fumou Deng; Gen Wei; Wei Deng; Jianyong Ma; Wengen Zhu; Jiru Zhang; Shuchun Yu
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.